News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
265,222 Results
Type
Article (14111)
Company Profile (282)
Press Release (250829)
Section
Business (79610)
Career Advice (152)
Deals (13718)
Drug Delivery (35)
Drug Development (50403)
Employer Resources (31)
FDA (5703)
Job Trends (5138)
News (144930)
Policy (10057)
Tag
Academia (905)
Alliances (21702)
Alzheimer's disease (796)
Antibody-drug conjugate (ADC) (75)
Approvals (5705)
Artificial intelligence (93)
Bankruptcy (103)
Best Places to Work (4573)
Biotechnology (232)
Breast cancer (130)
Cancer (1112)
Cardiovascular disease (88)
Career advice (132)
CAR-T (92)
Cell therapy (272)
Clinical research (40565)
Collaboration (436)
Compensation (184)
COVID-19 (1024)
C-suite (117)
Cystic fibrosis (74)
Data (1150)
Diabetes (105)
Diagnostics (1280)
Earnings (29251)
Events (47665)
Executive appointments (353)
FDA (6210)
Funding (414)
Gene editing (76)
Gene therapy (199)
GLP-1 (340)
Government (1073)
Healthcare (6582)
Infectious disease (1075)
Inflammatory bowel disease (105)
IPO (7264)
Job creations (860)
Job search strategy (127)
Layoffs (197)
Legal (1395)
Lung cancer (164)
Manufacturing (103)
Medical device (2581)
Medtech (2582)
Mergers & acquisitions (6691)
Metabolic disorders (315)
Neuroscience (1108)
NextGen: Class of 2025 (2024)
Non-profit (852)
Northern California (1340)
Obesity (166)
Opinion (96)
Parkinson's disease (89)
Patents (86)
People (25360)
Phase I (14318)
Phase II (18875)
Phase III (11925)
Pipeline (504)
Postmarket research (853)
Preclinical (5996)
Radiopharmaceuticals (211)
Rare diseases (249)
Real estate (1415)
Regulatory (8459)
Research institute (933)
Series A (82)
Southern California (1190)
Startups (1968)
United States (10544)
Vaccines (189)
Weight loss (96)
Date
Last 7 days (339)
Last 30 days (1447)
Last 365 days (20397)
2025 (2650)
2024 (20572)
2023 (22438)
2022 (26848)
2021 (27837)
2020 (23383)
2019 (16255)
2018 (11756)
2017 (13787)
2016 (11867)
2015 (14403)
2014 (10438)
2013 (7506)
2012 (7558)
2011 (7673)
2010 (7469)
Location
Africa (148)
Asia (17119)
Australia (2894)
California (3051)
Canada (966)
China (269)
Colorado (115)
Connecticut (130)
Delaware (72)
Europe (36861)
Florida (348)
Georgia (92)
Illinois (193)
Indiana (73)
Maryland (396)
Massachusetts (2387)
Minnesota (121)
New Jersey (762)
New York (835)
North Carolina (475)
Northern California (1340)
Ohio (98)
Pennsylvania (577)
South America (207)
Southern California (1190)
Texas (337)
Washington State (291)
265,222 Results for "rodin therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Vividion Therapeutics Announces Promotion of Jean Bemis to Chief Operating Officer
January 22, 2025
·
3 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Deals
Proteros, co-founder of Rodin Therapeutics, announces Rodin’s acquisition by Alkermes
Proteros biostructures GmbH announced that Rodin Therapeutics, Inc., a Boston, MA based biotech company developing novel, small molecule therapeutics for synaptopathies has been acquired by Alkermes plc, a global biopharmaceutical company headquartered in Dublin, Ireland.
December 3, 2019
·
1 min read
Press Releases
Anavo Therapeutics Appoints Dr. Edward Holson as Chief Scientific Officer and President US
October 9, 2024
·
3 min read
Press Releases
Tango Therapeutics to Present at Three Upcoming Investment Bank Conferences
February 20, 2025
·
1 min read
Press Releases
MiNK Therapeutics Regains Full Compliance with Nasdaq Listing Requirements
February 20, 2025
·
1 min read
Press Releases
Pharmacosmos Group and G1 Therapeutics Announce Expiration of Hart-Scott-Rodino Waiting Period
September 5, 2024
·
6 min read
Press Releases
Allogene Therapeutics Announces Participation in February Investor Conferences
February 4, 2025
·
2 min read
Press Releases
Denali Therapeutics Announces Upcoming Presentations on Hunter Syndrome (MPS II) and TransportVehicle™ Enabled Investigational Therapeutic Tividenofusp Alfa at the 2025 WORLDSymposium™
January 30, 2025
·
4 min read
Deals
Alkermes Buys Rodin Therapeutics to Bolster CNS Pipeline in $950 Million Deal
Under the terms of the deal, Alkermes is paying $100 million in cash upfront. Rodin will be eligible for future payments of up to $850 million based on clinical and regulatory milestones and sales thresholds.
November 18, 2019
·
3 min read
·
Mark Terry
1 of 26,523
Next
